Insulins (all types): risk of cutaneous amyloidosis at injection site

Cutaneous amyloidosis at the injection site has been reported in patients using insulin and this may affect glycaemic control. Patients should be reminded to rotate injection sites within the same body region.

Source:

Medicines and Healthcare products Regulatory Agency